China becomes a top five recipient of U.S. patents
January 23, 2018 Category China News Round-up, Weekly
For the first time the Chinese mainland has become a top five recipient of United States patents – behind the U.S., Japan, South Korea and Germany – according to a report by leading global patent consultancy IFI Claims Patent Services. The United States Patent and Trademark Office granted 320,003 patents in 2017, up 5.2% from the previous year. U.S. local companies received 46% of those patents, Asian companies 31% and European companies 15%.
Chinese mainland innovators were granted 11,241 U.S. patents last year. Although the number accounted for only 3.5% of the total, it still represented 28% year-on-year growth. “China is growing at an impressive rate,” said Larry Cady, Senior Analyst with IFI Claims. Bloomberg reported that the number of U.S. patents received annually by China increased tenfold over the past decade. IBM received more than 9,000 patents last year, making it the largest recipient for the 25th consecutive year. China’s Huawei Technologies ranked No 20 with 1,474 patent grants, the most among Chinese mainland companies. It was listed in the top 50 annual recipients for the first time in 2014.
The IFI Claims report also noted that Beijing-based display and sensing device developer BOE Technology Group was among those making the biggest increase among the top 50 recipients. It ranked No 21 last year with 1,413 granted US patents, up from No 40 in 2016. BOE Vice President Li Xinguo said Chinese companies were “making remarkable progress in high-tech innovation and international competitiveness”.
IFI Claims said eight technologies accounted for the biggest patent growth: e-cigarettes, 3-D printing, machine learning, autonomous vehicles, industrial moulding, hybrid vehicles, aerial drones and food, the China Daily reports.
- KURT VANDEPUTTE (UMICORE) APPOINTED CHAIRMAN OF THE BOARD OF THE FLANDERS-CHINA CHAMBER OF COMMERCE (FCCC)
- Webinar: “Knowing Your Chinese Partner” – May 26, 2021, 10 am – 12 am
- EMA starts rolling review of CoronaVac, WHO approves Sinopharm vaccine for emergency use
- The Global Times warns not to politicize the Comprehensive Agreement on Investment (CAI)
- Hainan to become biggest duty-free market in the world